©2009 Precision Therapeutics, Inc. All rights reserved. | 2516 Jane Street, Pittsburgh, PA 15203
Her cancer is being treated with 10 different chemotherapies.
But she isn't.
By testing multiple chemotherapies on a patient's cancer cells before treating a cancer patient, ChemoFx® helps determine the chemotherapies that are more likely to be effective and helps guide the physician away from therapies that are more likely to be ineffective- giving cancer patients a powerful advantage in the fight against cancer.But she isn't.
What is ChemoFx?
ChemoFx® is a drug response marker. It's a test that quantifies an individual cancer patient's probable tumor response to various chemotherapeutic and biologic agents—providing both sensitivity and resistance information. As such, ChemoFx® provides valuable insights that help guide physicians' treatment decisions and give both physicians and patients an edge against cancer.
